journal article·2021-02-23Open access

Integration of Multitargeted Polymer-Based Contrast Agents with Photoacoustic Computed Tomography: An Imaging Technique to Visualize Breast Cancer Intratumor Heterogeneity

Lei Li, Deepanjali Patil, Greg Petruncio, Kathleen K. Harnden, Jisha V. Somasekharan, Mikell Paige, Lihong V. Wang, Carolina Salvador-Morales

ACS Nano· Volume 15· Issue 2

Abstract

One of the primary challenges in breast cancer diagnosis and treatment is intratumor heterogeneity (ITH), i.e., the coexistence of different genetically and epigenetically distinct malignant cells within the same tumor. Thus, the identification of ITH is critical for designing better treatments and hence to increase patient survival rates. Herein, we report a noninvasive hybrid imaging technology that integrates multitargeted and multiplexed patchy polymeric photoacoustic contrast agents (MTMPPPCAs) with single-impulse panoramic photoacoustic computed tomography (SIP-PACT). The target specificity ability of MTMPPPCAs to distinguish estrogen and progesterone receptor-positive breast tumors was demonstrated through both fluorescence and photoacoustic measurements and validated by tissue pathology analysis. This work provides the proof-of-concept of the MTMPPPCAs/SIP-PACT system to identify ITH in nonmetastatic tumors, with both high molecular specificity and real-time detection capability.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Caltech Optical Imaging Laboratory, Andrew and Peggy Cherng Department of Medical Engineering and Department of Electrical Engineering, California Institute of Technology, Pasadena, California 91125, United States

Department of Chemistry & Biochemistry, George Mason University, 4400 University Drive, Fairfax, Virginia 22030, United States

Inova Schar Cancer Institute, 8081 Innovation, Park Drive, Fairfax, Virginia 22031, United States

Research and Post Graduate Department of Chemistry, MES Keveeyam College, Valanchery, Kerala 676552, India

Funding

Center for Innovative Technology · National Institutes of Health · National Science Foundation

References (60)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1002/cncr.3155110.1002/cncr.31551 ↗
3. 10.1111/his.1364210.1111/his.13642 ↗
4. 10.2217/epi-2018-021310.2217/epi-2018-0213 ↗
5. 10.3389/fmed.2017.0022710.3389/fmed.2017.00227 ↗
6. American Cancer Society. Breast Cancer Facts & Figures 2019–2020. 2019, https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020 (accessed March 11, 2020).10.6004/jadpro.2020.11.2.1 ↗
7. 10.1159/00035077410.1159/000350774 ↗
8. 10.1016/j.soc.2017.08.00510.1016/j.soc.2017.08.005 ↗
9. 10.7150/jca.1314110.7150/jca.13141 ↗
10. 10.1634/theoncologist.2017-053510.1634/theoncologist.2017-0535 ↗
11. 10.1038/s41523-020-0151-510.1038/s41523-020-0151-5 ↗
12. 10.1016/j.ctrv.2020.10196510.1016/j.ctrv.2020.101965 ↗
13. 10.1186/s13045-019-0798-210.1186/s13045-019-0798-2 ↗
14. 10.21037/atm.2020.03.19410.21037/atm.2020.03.194 ↗
15. 10.3390/cancers1206140410.3390/cancers12061404 ↗
16. 10.1158/0008-5472.CAN-15-064210.1158/0008-5472.CAN-15-0642 ↗
17. 10.3390/cancers1109128210.3390/cancers11091282 ↗
18. 10.1007/s12149-018-1253-010.1007/s12149-018-1253-0 ↗
19. 10.1111/tbj.1303210.1111/tbj.13032 ↗
20. 10.7150/thno.1667610.7150/thno.16676 ↗
21. 10.2967/jnumed.116.17559610.2967/jnumed.116.175596 ↗
22. 10.1186/s13058-016-0793-210.1186/s13058-016-0793-2 ↗
23. 10.5152/eurasianjmed.2018.1803610.5152/eurasianjmed.2018.18036 ↗
24. 10.2967/jnumed.115.15785910.2967/jnumed.115.157859 ↗
25. 10.2214/AJR.11.713010.2214/AJR.11.7130 ↗
26. 10.21037/abs.2019.02.0110.21037/abs.2019.02.01 ↗
27. 10.1038/s41467-018-05231-310.1038/s41467-018-05231-3 ↗
28. 10.1038/s41551-019-0376-510.1038/s41551-019-0376-5 ↗
29. 10.1126/scirobotics.aax061310.1126/scirobotics.aax0613 ↗
30. 10.1038/nmeth.365610.1038/nmeth.3656 ↗
31. 10.1038/nmeth.392910.1038/nmeth.3929 ↗
32. 10.1038/s41377-018-0090-110.1038/s41377-018-0090-1 ↗
33. 10.1117/1.JBO.22.7.07601710.1117/1.JBO.22.7.076017 ↗
34. 10.1016/j.pacs.2019.05.00110.1016/j.pacs.2019.05.001 ↗
35. 10.1038/nmeth.392510.1038/nmeth.3925 ↗
36. 10.1038/s41566-019-0576-210.1038/s41566-019-0576-2 ↗
37. 10.1038/nphoton.2009.9810.1038/nphoton.2009.98 ↗
38. 10.1117/1.NPh.3.3.03500110.1117/1.NPh.3.3.035001 ↗
39. 10.1038/s41566-019-0441-310.1038/s41566-019-0441-3 ↗
40. 10.1098/rsfs.2011.002810.1098/rsfs.2011.0028 ↗
41. 10.1038/s41551-017-007110.1038/s41551-017-0071 ↗
42. 10.1038/s41467-018-04576-z10.1038/s41467-018-04576-z ↗
43. 10.1038/srep4197010.1038/srep41970 ↗
44. 10.1158/1078-0432.CCR-16-320010.1158/1078-0432.CCR-16-3200 ↗
45. 10.1148/radiol.201918207110.1148/radiol.2019182071 ↗
46. 10.1007/s00330-019-06262-010.1007/s00330-019-06262-0 ↗
47. 10.1158/1078-0432.CCR-18-041710.1158/1078-0432.CCR-18-0417 ↗
48. 10.7150/thno.2128310.7150/thno.21283 ↗
49. 10.1021/acsabm.9b0103810.1021/acsabm.9b01038 ↗
50. 10.1021/acs.langmuir.6b0217710.1021/acs.langmuir.6b02177 ↗
51. 10.1021/acs.langmuir.5b0155110.1021/acs.langmuir.5b01551 ↗
52. 10.1002/smll.20120149910.1002/smll.201201499 ↗
53. Werner J. P. F. · BioRxiv · 2020 · 1
54. 10.1021/acssuschemeng.8b0209510.1021/acssuschemeng.8b02095 ↗
55. 10.1002/pola.2885610.1002/pola.28856 ↗
56. 10.1371/journal.pone.006900410.1371/journal.pone.0069004 ↗
57. 10.1093/bioinformatics/btu20210.1093/bioinformatics/btu202 ↗
58. Neu, B. W.; Cedrone, E.; Dobrovolskaia, M. A. NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles; National Characterization Lab: Frederick, MD, 2020; pp 1–17.
59. ASTM Standard Practice F 756-00. Assessment of Hemolytic Properties of Materials.
60. ASTM E2524-08 (2013) Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles.